Eli Lilly In Hot Seat Again Over Zyprexa

Law360, New York (January 22, 2007, 12:00 AM EST) -- Fresh off a $495 million product-liability settlement over Zyprexa, Eli Lilly & Co. is facing more scrutiny, with Illinois and Vermont requesting that the pharmaceutical giant hand over material detailing how it marketed the top-selling schizophrenia drug.

The New York Times reported on Saturday that state prosecutors in both Illinois and Vermont demanded last week that Eli Lilly turn over marketing materials, e-mail messages and other documents regarding Zyprexa’s advertising campaign.

With the requests, the states have now joined a larger, five-state civil investigation into the...
To view the full article, register now.

Law360 UK

UK Financial Services

Read Our Latest UK Legal News & Analysis

Financial Services Law360 UK and Insurance Law360 UK provide breaking news and in-depth analysis on U.K. and European Union regulation, enforcement, legislation, and litigation involving banks, investment firms, insurers, and more.